Management (mainly DM) is the reason why recent  private placements are priced out $1 to $2 USD, 

Our Peer Constellation Pharma got  bought out for $1.8 Billion USd and are clinically behind Zenith and we getting 20% valuation on our past PP . What a shame DM doesn't get some consulting and mangement help.  His ego is too big to move aside to bring in experienced biotech mangement , maybe Eversana can convince him to step aside ....